| Predicate |
Object |
| contentType |
Journal Article|Review |
| endingPage |
310 |
| issn |
1179-1950
0012-6667 |
| issueIdentifier |
3 |
| pageRange |
289-310 |
| publicationName |
Drugs |
| startingPage |
289 |
| bibliographicCitation |
Dib M. Amyotrophic lateral sclerosis: progress and prospects for treatment. Drugs. 2003;63(3):289–310. doi: 10.2165/00003495-200363030-00004. PMID: 12534333. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1a660e7ddb49f9fc5f09466583654ac7 |
| date |
200302 |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/12534333
https://doi.org/10.2165/00003495-200363030-00004 |
| isPartOf |
https://portal.issn.org/resource/ISSN/0012-6667
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3453
https://portal.issn.org/resource/ISSN/1179-1950 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
https://scigraph.springernature.com/ |
| title |
Amyotrophic lateral sclerosis: progress and prospects for treatment |
| discusses |
http://id.nlm.nih.gov/mesh/M0028006
http://id.nlm.nih.gov/mesh/M0028008
http://id.nlm.nih.gov/mesh/M0001491 |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6865
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d6e75560e5588a5e8000b5ba5e20faae
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_1.15.1.1
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5070 |